BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G951. A total of 4 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,043,536 | -44.8% | 45,700 | -45.9% | 0.01% | -41.7% |
| Q2 2023 | $7,324,460 | +115.2% | 84,500 | +141.4% | 0.02% | +100.0% |
| Q1 2023 | $3,403,400 | -74.7% | 35,000 | -73.1% | 0.01% | -61.3% |
| Q4 2022 | $13,453,700 | -18.4% | 130,000 | -33.2% | 0.03% | -3.1% |
| Q3 2022 | $16,488,000 | +57.0% | 194,500 | +53.5% | 0.03% | +100.0% |
| Q2 2022 | $10,500,000 | +13.6% | 126,700 | +5.7% | 0.02% | +77.8% |
| Q1 2022 | $9,244,000 | -51.7% | 119,900 | -44.6% | 0.01% | -40.0% |
| Q4 2021 | $19,128,000 | +3.2% | 216,500 | -9.8% | 0.02% | -25.0% |
| Q3 2021 | $18,542,000 | -7.8% | 239,900 | -0.5% | 0.02% | -16.7% |
| Q2 2021 | $20,117,000 | -9.5% | 241,100 | -18.1% | 0.02% | -27.3% |
| Q1 2021 | $22,238,000 | +10.6% | 294,500 | +28.4% | 0.03% | -5.7% |
| Q4 2020 | $20,107,000 | +47.9% | 229,300 | +28.3% | 0.04% | -18.6% |
| Q3 2020 | $13,596,000 | -12.5% | 178,700 | +41.8% | 0.04% | -40.3% |
| Q2 2020 | $15,541,000 | +162.4% | 126,000 | +79.7% | 0.07% | +50.0% |
| Q1 2020 | $5,923,000 | -8.4% | 70,100 | -8.4% | 0.05% | +9.1% |
| Q4 2019 | $6,468,000 | -31.7% | 76,500 | -45.6% | 0.04% | -42.9% |
| Q3 2019 | $9,476,000 | -43.2% | 140,600 | -27.9% | 0.08% | -49.0% |
| Q2 2019 | $16,693,000 | +252.5% | 194,900 | +265.7% | 0.15% | +184.9% |
| Q1 2019 | $4,735,000 | -40.2% | 53,300 | -42.7% | 0.05% | -23.2% |
| Q4 2018 | $7,919,000 | +19.9% | 93,000 | +36.6% | 0.07% | +32.7% |
| Q3 2018 | $6,604,000 | -4.4% | 68,100 | -7.1% | 0.05% | -11.9% |
| Q2 2018 | $6,905,000 | +93.1% | 73,300 | +66.2% | 0.06% | +63.9% |
| Q1 2018 | $3,575,000 | -89.3% | 44,100 | -88.2% | 0.04% | -84.7% |
| Q4 2017 | $33,439,000 | +275.4% | 375,000 | +291.8% | 0.24% | +190.1% |
| Q3 2017 | $8,907,000 | -33.2% | 95,700 | -34.9% | 0.08% | -41.7% |
| Q2 2017 | $13,341,000 | +59.0% | 146,900 | +53.7% | 0.14% | +41.8% |
| Q1 2017 | $8,392,000 | -31.0% | 95,600 | -34.9% | 0.10% | -16.9% |
| Q4 2016 | $12,161,000 | -29.7% | 146,800 | -21.5% | 0.12% | -37.2% |
| Q3 2016 | $17,301,000 | +150.2% | 187,000 | +110.3% | 0.19% | +129.3% |
| Q2 2016 | $6,916,000 | -9.3% | 88,900 | -3.8% | 0.08% | -24.1% |
| Q1 2016 | $7,621,000 | -34.0% | 92,400 | -16.2% | 0.11% | -21.2% |
| Q4 2015 | $11,555,000 | -42.9% | 110,300 | -42.6% | 0.14% | -51.1% |
| Q3 2015 | $20,253,000 | -39.2% | 192,300 | -21.1% | 0.28% | -39.9% |
| Q2 2015 | $33,333,000 | +34.2% | 243,700 | +22.3% | 0.47% | +19.5% |
| Q1 2015 | $24,837,000 | +166.7% | 199,300 | +93.5% | 0.39% | +176.6% |
| Q4 2014 | $9,311,000 | +95.5% | 103,000 | +56.1% | 0.14% | +93.2% |
| Q3 2014 | $4,763,000 | -17.9% | 66,000 | -29.3% | 0.07% | -18.0% |
| Q2 2014 | $5,804,000 | +141.7% | 93,300 | +165.1% | 0.09% | +122.5% |
| Q1 2014 | $2,401,000 | -50.0% | 35,200 | -48.5% | 0.04% | -45.2% |
| Q4 2013 | $4,806,000 | +673.9% | 68,400 | +695.3% | 0.07% | +508.3% |
| Q3 2013 | $621,000 | – | 8,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 146,800 | $12,161,000 | 0.12% |
| Hudson Bay Capital Management LP | 50,000 | $4,142,000 | 0.04% |
| SIMPLEX TRADING, LLC | 404 | $225,000 | 0.01% |
| Timber Hill LLC | 12,100 | $1,002,000 | 0.01% |
| JPMORGAN CHASE & CO | 40,000 | $3,314,000 | 0.00% |
| SG Americas Securities, LLC | 14,000 | $130,000 | 0.00% |